CSS Cost Benefit Analysis.docx PSYC4002 CSS Cost-Benefit Analysis Capella University PSYC4002: ABA Ethics and Supervision CSS Cost-Benefit Analysis CSS Cost-Benefit Analysis According to Dalphonse (2021), the na
...
CSS Cost Benefit Analysis.docx PSYC4002 CSS Cost-Benefit Analysis Capella University PSYC4002: ABA Ethics and Supervision CSS Cost-Benefit Analysis CSS Cost-Benefit Analysis According to Dalphonse (2021), the nature of the said behavior (aggression) is a behavior of imminent risk of harm to the environment such as assaulting others, kicking others, throwing objects at others head butting others, choking others, and pulling the hair of people in the environment: The CSS also treated the antecedents to the behavior with CSS. According to Banned Devices; Electrical Stimulation for Self-Injurious or Aggressive Behavior. Federal Register (2020) in such treatment as Contingency Skin Shock therapy, clients experienced many physiological and psychological effects such as physical pain, skin burns, tissue damage, depression, PTSD, anxiety, fear, panic, etc. This would say that medical staff other than 1 behavioral psychologist with a doctorate, teacher, the resident supervisor is not enough to see any of the above effects. It would appear the taking part staff does not have the specializations to use such treatment as contingency skin shock because of their lack of nursing or physician license, so it would be difficult to document medical results that aren™t physically observable. Although the setting may be healthy enough to live in, I don™t think it is a setting that should be a setting to apply such a treatment. Such treatment would seem to only be acceptable in a laboratory where the client can be ass. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . .. .. . . . . . . . . . . . . . . . . . .. . . . .
[Show More]